A novel missense mutation in the early growth response 2 gene associated with late-onset Charcot–Marie–Tooth disease type 1

Dyck, 1993, Hereditary motor and sensory neuropathies, 1094 Lupski, 1991, DNA duplication associated with Charcot–Marie–Tooth disease type 1A, Cell, 66, 219, 10.1016/0092-8674(91)90613-4 Chance, 1992, Analysis of the DNA duplication 17p11.2 in Charcot–Marie–Tooth neuropathy type 1 pedigrees: additional evidence for a third autosomal CMT1 locus, Neurology, 42, 2037, 10.1212/WNL.42.10.2037 Yamamoto, 1996, Locations of crossover breakpoints within the CMT1A-REP repeat in Japanese patients with CMT1A and HNPP, Hum. Genet., 99, 151, 10.1007/s004390050330 Hayasaka, 1993, Charcot–Marie–Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene, Nat. Genet., 5, 31, 10.1038/ng0993-31 Bergoffen, 1993, Connexin mutations in X-linked Charcot–Marie–Tooth disease, Science, 262, 2039, 10.1126/science.8266101 Warner, 1998, Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies, Nat. Genet., 18, 382, 10.1038/ng0498-382 Bellone, 1999, A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot–Marie–Tooth type 1 disease, Hum. Mutat., 14, 353, 10.1002/(SICI)1098-1004(199910)14:4<353::AID-HUMU17>3.0.CO;2-4 Timmerman, 1999, Novel missense mutation in the early growth response 2 gene associated with Dejerine–Sottas syndrome phenotype, Neurology, 52, 1827, 10.1212/WNL.52.9.1827 Latour, 1999, A R381H mutation in the EGR2 gene associated with a severe peripheral neuropathy with hypotonia, J. Peripheral Nervous System, 4, 293 Pareyson, 2000, Cranial nerve involvement in C.M.T. disease type 1 due to early growth response 2 gene mutation, Neurology, 54, 1696, 10.1212/WNL.54.8.1696 Yoshihara, 2000, Mutations in the peripheral myelin protein zero and connexin32 genes detected by non-isotopic RNase cleavage assay and their phenotypes in Japanese patients with Charcot–Marie–Tooth disease, Hum. Mutat., 349 Zorick, 1999, Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing Myelinating Schwann cells, Development, 126, 1397, 10.1242/dev.126.7.1397 Topilko, 1994, Krox-20 controls myelination in the peripheral nervous system, Nature, 371, 796, 10.1038/371796a0 Pavletich, 1991, Zinc finger–DNA recognition: crystal structure of a Zif268–DNA complex at 2.1A, Science, 252, 808, 10.1126/science.2028256 Rouger, 1996, High frequency of mutations in codon 98 of the peripheral myelin protein P0 gene in 20 French CMT1 patients, Am. J. Hum. Genet., 58, 638